Constellation Pharmaceuticals, Inc. IPO Research Information

Constellation Pharmaceuticals, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Constellation Pharmaceuticals, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Constellation Pharmaceuticals, Inc.	CNST - NASDAQ	$14.00-$16.00	$15.00	$11.48	4 million	7/19/2018
Underwriter(s): J.P. Morgan, Jefferies, BMO Capital Markets
Co-Manager(s): Oppenheimer & Co.
Industry: Health Care
Filing(s): Filed 2018-06-22 Terms Added 2018-07-09

Constellation Pharmaceuticals, Inc. Quote & Chart - Click for current quote - CNST

About Constellation Pharmaceuticals, Inc. (adapted from Constellation Pharmaceuticals, Inc. prospectus):
They are a clinical-stage biopharmaceutical company using our expertise in epigenetics to discover and develop novel therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "CNST" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.